Coronavirus medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{ADI}}
{{CMG}}; {{AE}} {{ADI}}
==Overview==
==Overview==
Treatment should be supportive. No specific treatment available. Most people with coronavirus illness will recover on their own.
Treatment of coronavirus [[infection]] includes supportive measures and [[Symptomatic treatment|symptomatic management]]. No specific treatment is available.
==Medical Therapy==
==Medical Therapy==
Treatment should be supportive. No specific treatment available. Most people with coronavirus illness will recover on their own. However, some things can be done to relieve symptoms.
Treatment should be supportive. No specific treatment available. Most people with coronavirus illness will recover on their own. However, some things can be done to relieve symptoms.
Line 11: Line 11:
* Drinking plenty of liquids, staying home and taking rest.
* Drinking plenty of liquids, staying home and taking rest.


:* '''Severe acute respiratory distress syndrome- coronavirus'''<ref>{{cite book | last = Gilbert | first = David | title = The Sanford guide to antimicrobial therapy 2014 | publisher = Antimicrobial Therapy | location = Sperryville, Va | year = 2014 | isbn = 978-1930808782 }}</ref><ref name="pmid16968120">{{cite journal| author=Stockman LJ, Bellamy R, Garner P| title=SARS: systematic review of treatment effects. | journal=PLoS Med | year= 2006 | volume= 3 | issue= 9 | pages= e343 | pmid=16968120 | doi=10.1371/journal.pmed.0030343 | pmc=PMC1564166 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16968120  }} </ref><ref name="pmid15766649">{{cite journal| author=Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T, Zabel P| title=Treatment and vaccines for severe acute respiratory syndrome. | journal=Lancet Infect Dis | year= 2005 | volume= 5 | issue= 3 | pages= 147-55 | pmid=15766649 | doi=10.1016/S1473-3099(05)01307-1 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15766649  }} </ref>
:*'''Severe acute respiratory distress syndrome- coronavirus'''<ref>{{cite book | last = Gilbert | first = David | title = The Sanford guide to antimicrobial therapy 2014 | publisher = Antimicrobial Therapy | location = Sperryville, Va | year = 2014 | isbn = 978-1930808782 }}</ref><ref name="pmid16968120">{{cite journal| author=Stockman LJ, Bellamy R, Garner P| title=SARS: systematic review of treatment effects. | journal=PLoS Med | year= 2006 | volume= 3 | issue= 9 | pages= e343 | pmid=16968120 | doi=10.1371/journal.pmed.0030343 | pmc=PMC1564166 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16968120  }} </ref><ref name="pmid15766649">{{cite journal| author=Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T, Zabel P| title=Treatment and vaccines for severe acute respiratory syndrome. | journal=Lancet Infect Dis | year= 2005 | volume= 5 | issue= 3 | pages= 147-55 | pmid=15766649 | doi=10.1016/S1473-3099(05)01307-1 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15766649  }} </ref>
:*Preferred regimen: supportive therapy
:*Preferred regimen: supportive therapy
:*Note: New therapies were studied for SARS during the last outbreaks which concluded:
:*Note: New therapies were studied for SARS during the last outbreaks which concluded:

Revision as of 15:14, 5 February 2020

Coronavirus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Coronavirus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Electrocardiogram

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Coronavirus medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Coronavirus medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Coronavirus medical therapy

CDC on Coronavirus medical therapy

Coronavirus medical therapy in the news

Blogs on Coronavirus medical therapy

Directions to Hospitals Treating Coronavirus

Risk calculators and risk factors for Coronavirus medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Treatment of coronavirus infection includes supportive measures and symptomatic management. No specific treatment is available.

Medical Therapy

Treatment should be supportive. No specific treatment available. Most people with coronavirus illness will recover on their own. However, some things can be done to relieve symptoms.

  • Taking pain and fever medications (aspirin should not be given to children).
  • Using a room humidifier or taking a hot shower to help ease a sore throat and cough.
  • Drinking plenty of liquids, staying home and taking rest.
  • Severe acute respiratory distress syndrome- coronavirus[1][2][3]
  • Preferred regimen: supportive therapy
  • Note: New therapies were studied for SARS during the last outbreaks which concluded:
  • Ribavirin ineffective and probably harmful due to haemolytic anaemia
  • Lopinavir PLUS Ritonavir is still controversial and need further investigation
  • Interferon has no benefit and its studies are inconclusive
  • Corticosteroids increases risk of fungal infections, some studies showed a higher incidence of psychosis, diabetes, avascular necrosis and osteoporosis
  • Inhaled Nitric oxide potent mediator of airway inflammation, its has improved oxygenation in some studies

References

  1. Gilbert, David (2014). The Sanford guide to antimicrobial therapy 2014. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808782.
  2. Stockman LJ, Bellamy R, Garner P (2006). "SARS: systematic review of treatment effects". PLoS Med. 3 (9): e343. doi:10.1371/journal.pmed.0030343. PMC 1564166. PMID 16968120.
  3. Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T, Zabel P (2005). "Treatment and vaccines for severe acute respiratory syndrome". Lancet Infect Dis. 5 (3): 147–55. doi:10.1016/S1473-3099(05)01307-1. PMID 15766649.

Template:WH Template:WS